Switzerland Startup Ecosystem

Overview

Switzerland's startup ecosystem is highly advanced, with Zurich and Geneva being key hubs for innovation. As of 2023, Switzerland is home to around 5,000 startups. The Swiss government supports innovation through initiatives like Innosuisse and the Swiss National Science Foundation, which provide funding, resources, and mentorship for startups. In 2022, Swiss startups raised approximately €2 billion in venture capital. These factors collectively highlight Switzerland's dynamic and evolving startup landscape.

Size of the Market

As of 2023, Switzerland's startup ecosystem includes around 5,000 startups. In 2022, these startups attracted approximately €2 billion in venture capital funding. This substantial investment underscores the ecosystem's growth potential and robust nature. The market's size and financial backing reflect its capacity to foster innovation and sustain a competitive edge within Europe and beyond.

Key Strengths

Switzerland's startup ecosystem is characterized by several key strengths, including a highly educated workforce, a strong financial sector, and world-class research institutions. The country excels in sectors such as fintech, healthtech, and cleantech. These strengths are bolstered by Switzerland's robust industrial base and government support, positioning it as a leader in the European startup scene.

Major Hubs

Zurich and Geneva are the primary hubs of Switzerland’s startup ecosystem. Zurich is known for its strengths in fintech, healthtech, and cleantech, attracting significant investments and producing notable startups like Climeworks and Nexthink. Geneva has a vibrant tech scene with strengths in biotech and international trade. These cities are instrumental in driving Switzerland's economic growth and technological advancements.

Emerging Hubs

In addition to Zurich and Geneva, emerging hubs like Lausanne and Basel are gaining prominence in Switzerland’s startup ecosystem. Lausanne, home to EPFL, is strong in deep tech and medtech, while Basel is a hub for pharmaceuticals and life sciences. These emerging hubs are expanding the reach and diversity of Switzerland’s entrepreneurial landscape, offering new opportunities for innovation and growth.

Support Systems

Switzerland’s startup ecosystem benefits from a strong network of incubators, accelerators, and co-working spaces that provide essential support and resources for entrepreneurs. Initiatives like Venturelab and the Swiss Innovation Park have significantly boosted the ecosystem by offering mentorship, resources, and international exposure. This supportive infrastructure is crucial for nurturing early-stage companies and fostering a collaborative entrepreneurial environment.

Challenges

Despite its strengths, the Swiss startup ecosystem faces challenges such as high living costs and regulatory complexities. Navigating these hurdles can be time-consuming and complex for startups. Addressing these issues requires strategic efforts and supportive policies to sustain growth and competitiveness in the global market.

Opportunities and Future Outlook

Switzerland has significant opportunities for growth in sectors like fintech, healthtech, and cleantech. The country's strong focus on sustainability and green technology drives innovation in renewable energy and environmental technologies. Switzerland's strategic location in Europe and strong trade relationships provide startups with opportunities for international expansion. With continued investment and innovation, Switzerland's startup ecosystem is poised for further growth, contributing significantly to the European and global markets.

Resilience and Adaptability

Switzerland's startup ecosystem demonstrates remarkable resilience and adaptability. The country's commitment to innovation, coupled with strong government and institutional support, enables startups to navigate challenges and capitalize on opportunities. The diverse talent pool and high level of digitalization attract entrepreneurs and investors alike, ensuring sustained growth and success in the face of global economic shifts and market dynamics.

overlay landing page

We found 262 VC firms in Switzerland investing in BioTech on Angels Partners

main investor picture
Giovanni Leo
Investing in IT (& TMT) • Media • BioTe...
 Geneva, Switzerland
Investor Picture
Previous Investments
  • EBAMed: (early stage)
  • Innogest Capital:
  • MedLumics, S.L.: (late stage)
  • Anaconda BioMed: (early stage)
  • CV Lab - Cardiovascular Laboratory: (early stage)
  • Medyria: (early stage)
  • Endosense: (early stage)
  • ISO-MET:
  • CTERA Networks:
  • Silverfort Security:
  • Cato Networks: (early stage)
  • Fireglass: (early stage)
  • Teridion: (early stage)
  • Singtel Innov8 Ventures LLC:
  • Carmel Ventures:

Giovanni Leo

Geneva, Switzerland

Investing In

IT (& TMT) • Media • BioTech • Energy • CleanTech • Web Security (& Privacy) • Material Science • Medical Devices (& Hospital Services)

Description

Partner at Innogest Capital

Partner at Innogest Capital

main investor picture
Hunter Walk
Investing in Software (Web Marketplace Saas..) &b...
 San Francisco Bay Are..., U.S.A. - Global: U.S.A., Australia, Canada, Germany, U.K., Israel, France, Italy, Spain, Netherlands, Belgium, Switzerland, Denmark, Finland, Luxembourg, Malta, Iceland
Investor Picture
Previous Investments
  • Candor, Inc.: (Seed Round)
  • Habi: $5500000 (Early stage VC)
  • Alula (Other Healthcare Technology Systems): $2200000 (Seed Round)
  • Outlier (AI):
  • Reken: $10000000 (Seed)
  • Granola: $4000000 (Seed)
  • koodos: (Seed)
  • Resq: $39000000 (Series A)
  • Resq: $8000000 (Seed)
  • Assembly: $5000000 (Seed)
  • LIT Videobooks: $5000000 (Seed)
  • Graphite: (Seed)
  • Sanzo: $1000000 (Seed)
  • Sanzo: $1300000 (Seed Round)
  • Arthur: $3000000 (Seed)
  • Thingtesting: $300000 (Pre Seed)
  • 1 Second Everyday: (Seed)
  • Projector: $9000000 (Series A)
  • Nautilus Labs: $2000000 (Seed)
  • Radical Candor: (Seed)
  • TrueAccord: $5000000 (Series A)
  • Shyp: $2000000 (Seed)
  • Sunrise: $2000000 (Seed)
  • Wealthfront: $20000000 (Series B)
  • Schematic Labs: (Seed)
  • Path 101: $350000 (Angel)

Hunter Walk

San Francisco Bay Area - California, U.S.A. - Global: U.S.A., Australia, Canada, Germany, U.K., Israel, France, Italy, Spain, Netherlands, Belgium, Switzerland, Denmark, Finland, Luxembourg, Malta, Iceland

Investing In

Software (Web Marketplace Saas..) • BioTech • FinTech (& Financials services)

Description

Hunter Walk is a Co-Founder and serves as a Partner at Homebrew. He served as Board Member Shyp. He also serves as an Advisor at Resolute Ventures. Prior to Homebrew, Hunter was VP of Product at Twitter, building and leading the Product Management and User Services tea Before Twitter, he was a Partner at Battery Ventures, where he co-led the seed and early stage investing practices. He joined Google in 2003 and was responsible for AdSense product management and partnerships. Before heading to Silicon Valley for Google, he worked for DoubleClick, in venture capital and as a strategy consultant. He holds an MBA from Stanford Graduate School of Business and a BA in History from Vassar College.

main investor picture
Seventure Partners
Investing in Software (Web Marketplace Saas..) &b...
 Basel, France
  • main investor picture
    Bruno Rivet
    Associate
  • main investor picture
    Jonathan Cohen Sabban
    Ankaa Ventures
  • main investor picture
    David Manjarres
    General Partner
  • main investor picture
    Emmanuel Fiessinger
    General Partner
  • main investor picture
    Pierre Aumeunier
    CFO
  • main investor picture
    Maxime Mandin
    Investment Director
  • main investor picture
    Isabelle de Cremoux
    Managing Partner
  • main investor picture
    Sébastien Groyer
    Partner
  • main investor picture
    Camille Curtil
    Associate
  • main investor picture
    Guillaume Echaudemaison
    Analyst
  • main investor picture
    Thibault Canton
    Partner
  • main investor picture
    Andreas Schenk
    Venture Partner
  • main investor picture
    Arthur Bourgade
    Analyst
  • main investor picture
    Guilhem Stoll
    Analyst
  • main investor picture
    Quang Lê
    Analyst
  • main investor picture
    Isabelle Cremoux
    Partner
  • main investor picture
    LaItitia Gerbe
    Partner
Investor Picture
Previous Investments
  • Axial Therapeutics: $37300000 (Series C)
  • Galecto: $92040000 (Later stage VC)
  • Launchmetrics: $50000000 (Later stage VC)
  • Tibot Technologies: $3300000 (Early stage VC)
  • Kinomap:
  • CouchCommerce: (Seed Round)
  • Nexess: $4000000 (Series Unknown)
  • Pitchy: $43000000 (Series B)
  • Pitchy: $7000000 (Series A)
  • Presto Engineering: (Series Unknown)
  • Presto Engineering: $2000000 (Series Unknown)
  • E-Blink: $4000000 (Series Unknown)
  • E-Blink: $9000000 (Series Unknown)
  • E-Blink: $8000000 (Series Unknown)
  • Otoqi: $11000000 (Series B)
  • Glopal: $22000000 (Series A)
  • Domain Therapeutics: $41000000 (Series A)
  • Domain Therapeutics: $4000000 (Series Unknown)
  • Domain Therapeutics: $2000000 (Series Unknown)
  • Aenitis Technologies: (Series Unknown)
  • Aenitis Technologies: (Series Unknown)
  • Scipio Bioscience: $7000000 (Series A)
  • Scipio Bioscience: $1000000 (Seed)
  • Oxxon Therapeutics: $24000000 (Series Unknown)
  • Proteon Pharmaceuticals: $25000000 (Series Unknown)
  • Proteon Therapeutics: $25000000 (Post Ipo Equity)
  • Syroco: $8000000 (Series A)
  • Citryll: $90000000 (Series B)
  • Citryll: $21000000 (Series B)
  • Sequentia Biotech: $11000000 (Series A)
  • Exo: $1000000 (Seed)
  • MaaT Pharma: $20000000 (Post Ipo Equity)
  • Karius: $100000000 (Series C)
  • Starfish Bioscience: $970000 (Seed)
  • Inalve: $2000000 (Series Unknown)
  • Sinay: $5000000 (Series A)
  • Graphite Innovation & Technologies: $7000000 (Series A)
  • Clinical Microbiomics: $10000000 (Series Unknown)
  • Polaris: $6000000 (Seed)
  • Cytoki Pharma: $45000000 (Series A)
  • ENTEROME: $52000000 (Series E)
  • ENTEROME: $48000000 (Debt Financing)
  • ENTEROME: $34000000 (Series D)
  • ENTEROME: $16000000 (Series C)
  • ENTEROME: $15000000 (Series B)
  • ENTEROME: $10000000 (Series A)
  • ENTEROME: $2000000 (Seed)
  • MycoTechnology: $39000000 (Series D)
  • MycoTechnology: $42000000 (Series B)
  • MycoTechnology: $9000000 (Series A)
  • LNC Therapeutics: $7000000 (Series Unknown)
  • LNC Therapeutics: $8000000 (Series C)
  • LNC Therapeutics: $5000000 (Series B)
  • String Bio: (Series Unknown)
  • Microbiotica: $5000000 (Series Unknown)
  • machtfit: $3000000 (Series A)
  • Anaeropharma Science: $13000000 (Series Unknown)
  • Push Doctor: $26000000 (Series B)
  • Fluxome: $20000000 (Series B)
  • Fluxome: $7000000 (Series Unknown)
  • Axial Biotherapeutics: $37000000 (Series C)
  • Abalos Therapeutics: $36000000 (Series A)
  • Dopavision: $14000000 (Series A)

Seventure Partners

Basel, France

Investing In

Software (Web Marketplace Saas..) • Other • IT (& TMT) • Media • BioTech • AgroTech • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • Retail (& E-Commerce) • CleanTech • HealthTech (& Fitness) • Food & Beverage • Material Science • Medical Devices (& Hospital Services) • DeepTech • Healthcare (& Wellness) • Mobile • Consumer • Pharmaceutical (& Medicine)

Description

Seventure Partners is a venture capital firm that seek to invest in the hardware and telecommunication, information technology and life sciences sectors. The firm was founded in 1997 and is based in Paris, France.

main investor picture
Pejman Nozad
Investing in BioTech • A.I. (& Big Data) &bu...
 Palo Alto - California, U.S.A. - Global: U.S.A., Australia, Canada, Germany, U.K., Israel, France, Italy, Spain, Netherlands, Belgium, Switzerland, Denmark, Finland, Luxembourg, Malta, Iceland
Investor Picture
Previous Investments
  • Run the World: $11000000 (Later stage VC)
  • Learn To Win: $4000000 (Early stage VC)
  • Xilis: $3000000 (Seed Round)
  • Guild Technology: $2880000 (Seed Round)
  • SellScale: $3000000 (Seed)
  • Thena: $2000000 (Pre Seed)
  • SoundHound: $110000000 (Post Ipo Equity)
  • Maker Wine: (Pre Seed)
  • Fieldbook: $2000000 (Seed)
  • Fieldbook: $730000 (Seed)
  • Guardant Health: $100000000 (Series D)
  • Guardant Health: $30000000 (Series B)
  • Philz Coffee: $15000000 (Series B)
  • Evergive: $1000000 (Seed)
  • True&Co: $4000000 (Series A)
  • DoorDash: $2000000 (Seed)
  • EagerPanda: $3000000 (Seed)
  • Graphdive: $2000000 (Series A)
  • Graphdive: $1000000 (Seed)
  • Heap: $2000000 (Seed)
  • Sensor Tower: $1000000 (Seed)
  • Filestack: $2000000 (Seed)
  • Wedding Party: $1000000 (Seed)
  • RolePoint: $5000000 (Seed)
  • Gusto: $6000000 (Seed)
  • FundersClub: $7000000 (Seed)
  • Contacts+: $1000000 (Seed)
  • Keen: $750000 (Seed)
  • NationBuilder: $6000000 (Series A)
  • Peek: $1000000 (Seed)
  • Qwiki: $8000000 (Series A)
  • Badgeville: $3000000 (Series A)
  • Zetta: $11000000 (Series A)
  • Aquantia: $26000000 (Series B)
  • Aquantia: $12000000 (Series A)
  • Dropbox: $1000000 (Seed)
  • Project Playlist: $3000000 (Series A)
  • AddThis: $10000000 (Series B)
  • Lending Club: $2000000 (Angel)
  • Causes: $2000000 (Series A)
  • Powerset: $13000000 (Series A)
  • LiteScape Technologies: $8000000 (Series A)

Pejman Nozad

Palo Alto - California, U.S.A. - Global: U.S.A., Australia, Canada, Germany, U.K., Israel, France, Italy, Spain, Netherlands, Belgium, Switzerland, Denmark, Finland, Luxembourg, Malta, Iceland

Investing In

BioTech • A.I. (& Big Data) • Blockchain (& Cryptos) • Autonomous vehicles (& Cars) • Cloud Services (& Infrastructure) • Developer tools • Consumer

Description

Most Interested In

API E-Commerce Education Enterprise Fintech Food and Beverage Future of Work Gaming Government Technology Hardware Health and Wellness Healthcare/Medtech Industrial Internet and Mobile IoT Life Sciences Productivity Proptech/Real Estate Robotics SaaS Social Supply Chain/Logistics Transportation Travel/Hospitality

main investor picture
Ann MiuraKo
Investing in Software (Web Marketplace Saas..) &b...
 Palo Alto , Austin , ..., U.S.A. - Global: U.S.A., Australia, Canada, Germany, U.K., Israel, France, Italy, Spain, Netherlands, Belgium, Switzerland, Denmark, Finland, Luxembourg, Malta, Iceland
Investor Picture
Previous Investments
  • Ayasdi: $55000000 (Series C)
  • Ayasdi: $30600000 (Series B)
  • Ayasdi: $182000 (Venture Round)
  • Ayasdi: $10000000 (Series A)
  • Ayasdi: (Seed Round)
  • Monthly: (Seed Round)
  • Mem Labs: $5600000 (Seed Round)
  • Openlayer: $5000000 (Seed)
  • OpsLevel: $15000000 (Series A)
  • Svix: $3000000 (Pre Seed)
  • Lowkey: $7000000 (Series A)
  • Wasmer: (Seed)
  • Atmos: $2000000 (Seed)
  • Let’s Do This: $5000000 (Seed)
  • Red Planet Labs: $5000000 (Seed)
  • Universe: $4000000 (Series A)
  • DocTalk: (Seed)
  • Riley: $3000000 (Seed)
  • Upgraded: $1000000 (Seed)
  • Vetcove: $3000000 (Seed)
  • Flexport: $4000000 (Seed)
  • Flexport: $7000000 (Series A)
  • Observe AI: $5000000 (Seed)
  • Popshop Live: $20000000 (Series A)
  • Popshop Live: $3000000 (Seed)
  • Popshop Live: $3000000 (Seed Round)
  • Merlin Labs: $25000000 (Series A)
  • Merlin Labs: $4000000 (Seed)
  • Mem: $6000000 (Seed)
  • Hebbia: $1000000 (Pre Seed)
  • Emotive: $6000000 (Series A)
  • Emotive: $3000000 (Seed)
  • Bot M.D.: $920000 (Seed Round)
  • Bot MD: $2000000 (Seed)
  • Studio: (Seed)
  • Chairman Mom: $1000000 (Seed)
  • Thinkful: $10000000 (Series A)
  • Thinkful: $5000000 (Seed)
  • JoyRun: $9000000 (Series A)
  • Labdoor: $3000000 (Series A)
  • ModCloth: $15000000 (Series C)
  • ModCloth: $25000000 (Series C)
  • ModCloth: $20000000 (Series B)
  • ModCloth: $2000000 (Series A)
  • Maker Media: $5000000 (Series A)
  • Maker Media: $5000000 (Series Unknown)
  • Mixmax: $3000000 (Seed)
  • SymphonyAI Sensa: $55000000 (Series C)
  • SymphonyAI Sensa: $31000000 (Series B)
  • SymphonyAI Sensa: $180000 (Series Unknown)
  • SymphonyAI Sensa: $10000000 (Series A)
  • SymphonyAI Sensa: (Seed)
  • Xamarin: $54000000 (Series C)
  • Xamarin: $16000000 (Series B)
  • Xamarin: $13000000 (Series A)
  • Airphrame: $4000000 (Series A)
  • Airphrame: (Seed)
  • Chloe + Isabel: $15000000 (Series C)
  • Chloe + Isabel: $9000000 (Series A)
  • Chloe + Isabel: $3000000 (Seed)
  • Tango Card: $3000000 (Series B)
  • Tango Card: $4000000 (Series B)
  • Wanelo: (Series A)
  • Wanelo: $3000000 (Series Unknown)
  • Complete Solar: $5000000 (Series Unknown)
  • Complete Solar: (Series A)
  • Rise: $2000000 (Seed)
  • Lyft: $15000000 (Series B)
  • Lyft: $6000000 (Series A)
  • Lyft: $1000000 (Seed)
  • Refinery29: $6000000 (Series B)
  • Refinery29: $4000000 (Series A)
  • One Jackson: $2000000 (Seed)
  • Taskrabbit: $18000000 (Series B)
  • Taskrabbit: $5000000 (Series A)
  • Taskrabbit: $850000 (Seed)
  • Taskrabbit: $1000000 (Seed)
  • Pipewise: $4000000 (Series A)
  • Dasient: $2000000 (Seed)

Ann MiuraKo

Palo Alto - Austin - Salt Lake City - Provo - Seattle - Boston / New - New York - San Jose - San Francisco Bay Area - California, U.S.A. - Global: U.S.A., Australia, Canada, Germany, U.K., Israel, France, Italy, Spain, Netherlands, Belgium, Switzerland, Denmark, Finland, Luxembourg, Malta, Iceland

Investing In

Software (Web Marketplace Saas..) • BioTech • FinTech (& Financials services) • HealthTech (& Fitness) • Future Of Work • Medical Devices (& Hospital Services) • DeepTech • Healthcare (& Wellness)

Description

Most Interested In

I'm looking for prime movers that are developing auto-pilot for the intelligent enterprise particularly in network and software monitoring, HR, sales, and supply chain. In consumer: marketplaces and anything with high engagement

Not Interested In

e-commerce / retail / ad optimization

main investor picture
Piotr Kulesza
Investing in Software (Web Marketplace Saas..) &b...
 Berlin, Germany - Europe: Germany, United Kingdom, France, Italy, Spain, Poland, Romania, Netherlands, Belgium, Czech Republic, Greece, Portugal, Sweden, Hungary, Austria, Switzerland, Denmark, Finland, Slovakia, Norway, Ireland, Luxembourg, Malta, Iceland, Monac
Investor Picture
Previous Investments
  • Eversports: $5920000 (Early stage VC)
  • MNM Diagnostics:
  • Point Nine Capital: (mid stage)
  • RTAventures VC: (early stage)
  • Q Corporate Finance House:

Piotr Kulesza

Berlin, Germany - Europe: Germany, United Kingdom, France, Italy, Spain, Poland, Romania, Netherlands, Belgium, Czech Republic, Greece, Portugal, Sweden, Hungary, Austria, Switzerland, Denmark, Finland, Slovakia, Norway, Ireland, Luxembourg, Malta, Iceland, Monac

Investing In

Software (Web Marketplace Saas..) • BioTech • HealthTech (& Fitness) • Healthcare (& Wellness) • Consumer • Woman Focused

Description

Founder and General Partner at RTA.vc

Most Interested In

I'm interested in early stage VC funds (including solo GPs). I invested among others in these funds: Point Nine Capital, Adjacent, RABA Partnership, Market One Capital, Amino Collective.



Piotr Kulesza is a Co-Founder & Managing Partner at RTAventures. He is an Angel Investor. He served as Advisor of Infermedica. He also serves as an Advisor at Point Nine Capital.He is engaged in the investments of Poland since 1998. In 2009-2011 worked in the venture fund managed by Enterprise Investors, where he made an investment in the Polish Stem Cell Bank, currently the third-largest bank umbilical cord blood Europe - www.famicord .eu. During the years 2002-2009 has advised on several projects, purchase or sale of companies in Poland and Central and Eastern Europe leading his own investment boutique.

main investor picture
Alexander Elenskiy
Investing in Software (Web Marketplace Saas..) &b...
 Palo Alto California ..., Singapore
Investor Picture
Previous Investments
  • Wheelys:
  • Ambronite Inc: (early stage)
  • Faraday Bicycles: (mid stage)
  • Open Streets:
  • Wheely's Cafe International: (early stage)
  • TripleMint: (mid stage)
  • Blueprint Health LLC: (early stage)
  • Numedii:
  • OM Signal:
  • Ringadoc: (mid stage)
  • TransferWise: (early stage)
  • Voximplant:
  • Zesty, Inc.: (early stage)
  • GrabCAD: (mid stage)
  • Stroma Medical:
  • Twitter:
  • Koemei: (early stage)
  • Lumobodytech:
  • Retrofit:
  • Seedcamp: (mid stage)
  • Xatori, Inc (acquired by Recargo): (early stage)
  • Zingaya: (early stage)
  • Naive Angels Fund:
  • NanoLabs:
  • Tentech:

Alexander Elenskiy

Palo Alto California - United Kingdom; Switzerland; Lausanne Switzerland; Moscow Russia; London United Kingdom; San Francisco California United State, Singapore

Investing In

Software (Web Marketplace Saas..) • IT (& TMT) • Media • Education • BioTech • Businesses Solutions • Hardware (& Manufacturing) • Energy • Retail (& E-Commerce) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Gaming (& eSports) • Autonomous vehicles (& Cars) • Robotics • Healthcare (& Wellness) • Mobile • Consumer

Description

Daydreamer Fund, Partner

Alexander Elenskiy serves as Board Member and Investor at Zingaya. Elenskiy is an Angel Investor and is an Investor in Wheely's Cafe International, Ambronite and Faraday Bicycles. He received his Master's degree in Law from Lomonosov Moscow State University.

main investor picture
Pascal Levensohn
Investing in Software (Web Marketplace Saas..) &b...
 San Francisco Bay Are..., Switzerland - U.S.A.
Investor Picture
Previous Investments
  • Radiance: $26000000 (Later stage VC)
  • Bunch (Entertainment Software): $20050000 (Later stage VC)
  • Ubicom: $7000000 (Later stage VC)
  • Mojo Vision: $50000000 (Later stage VC)
  • Stellar Labs: $26300000 (Early stage VC)
  • Digilens: $22000000 (Later stage VC)
  • Sea Machines: $20000000 (Later stage VC)
  • Ultrahaptics: $17900000 (Later stage VC)
  • Alzeca Biosciences: $11000000 (Early stage VC)
  • Cortexyme: $7600000 (Later stage VC)
  • Echo: $7500000 (Early stage VC)
  • Envisagenics, Inc.: $2400000 (Seed Round)
  • M3 Biotechnology: $1400000 (Later stage VC)
  • ShotSpotter: $10000000 (Series Unknown)
  • ShotSpotter: $12000000 (Series Unknown)
  • ShotSpotter: $7000000 (Series Unknown)
  • ShotSpotter: $11000000 (Series Unknown)
  • ShotSpotter: $8000000 (Series D)
  • ShotSpotter: $12000000 (Series C)
  • Therini Bio: $36000000 (Series A)
  • Therini Bio: $17000000 (Seed)
  • Therini Bio: $9000000 (Seed)
  • GenomSys: $9000000 (Series A)
  • Lightform: $9000000 (Series A)
  • Lightform: $5000000 (Seed)
  • Modsy: $8000000 (Series A)
  • SoundThinking: $10000000 (Series Unknown)
  • SoundThinking: $12000000 (Series Unknown)
  • SoundThinking: $7000000 (Series Unknown)
  • SoundThinking: $11000000 (Series Unknown)
  • SoundThinking: $8000000 (Series D)
  • SoundThinking: $12000000 (Series C)
  • Mixed Dimensions: $4000000 (Convertible Note)
  • Hooja: $1000000 (Seed)
  • Akros Silicon: $10000000 (Series B)

Pascal Levensohn

San Francisco Bay Area - Geneva, Switzerland - U.S.A.

Investing In

Software (Web Marketplace Saas..) • BioTech • HealthTech (& Fitness) • Web Security (& Privacy) • Medical Devices (& Hospital Services)

Description

Senior Managing Director at Dolby Family Ventures

main investor picture
Peter Niederhauser
Investing in BioTech • Consumer
 Zurich, Switzerland
Investor Picture
Previous Investments
  • Finiata: $10000000 (Early stage VC)
  • Portify: $9070000 (Early stage VC)
  • Lunaphore Technologies: $6000000 (Later stage VC)
  • Versantis: $4400000 (Early stage VC)
  • Aktiia: $4130000 (Early stage VC)
  • Inkitt: $3900000 (Other)
  • Home: $3000000 (Seed Round)
  • Zenjob: $3000000 (Early stage VC)
  • Genialis: $2300000 (Seed Round)
  • Taxfix: $2000000 (Seed Round)
  • Morressier: $1700000 (Seed Round)
  • Felmo:
  • Luya Foods: $6000000 (Series A)
  • Carvolution: $16000000 (Series D)
  • Relai: $3000000 (Seed)
  • Kenjo: $6000000 (Seed)
  • N26: $100000000 (Series D)
  • N26: $300000000 (Series D)
  • N26: $40000000 (Series B)
  • N26: $11000000 (Series A)
  • N26: $2000000 (Seed)
  • bexio: $7000000 (Series Unknown)
  • bexio: $5000000 (Series B)
  • JUNIQE: $16000000 (Series B)
  • JUNIQE: $6000000 (Series A)
  • JUNIQE: $2000000 (Seed)
  • TrekkSoft: $600000 (Seed)
  • TrekkSoft: $800000 (Seed)
  • TrekkSoft: $800000 (Seed)
  • Givve: $370000 (Series A)
  • Givve: $2000000 (Series A)
  • InSphero: $2000000 (Series A)

Peter Niederhauser

Zurich, Switzerland

Investing In

BioTech • Consumer

Description

Founder & Partner at Redalpine Venture Partners

main investor picture
mike edelhart
Investing in BioTech • IoT (& Wearables) &bu...
 San Francisco Bay Are..., U.S.A. - Global: U.S.A., Australia, Canada, Germany, U.K., Israel, France, Italy, Spain, Netherlands, Belgium, Switzerland, Denmark, Finland, Luxembourg, Malta, Iceland
Investor Picture
Previous Investments
  • Panda: $850000
  • Seated (Media and Information Services (B2B)): $30000000 (Later stage VC)
  • BioAesthetics: $6400000 (Early stage VC)
  • Andie: $4390000 (Early stage VC)
  • Planted (Food Products):
  • Sigrid Therapeutics: $8000000 (Series Unknown)
  • Oga: $500000 (Seed)
  • Fulcrum: $3000000 (Seed)
  • Original Stitch: (Seed)
  • Original Stitch: $250000 (Seed)
  • Original Stitch: $1000000 (Seed)
  • Boundless Mind: (Seed)
  • Boundless Mind: $1000000 (Seed)
  • Boundless Mind: $100000 (Seed)
  • Boundless Mind: (Convertible Note)
  • Scatter: $4000000 (Seed)
  • Scatter: $1000000 (Convertible Note)
  • Mycroft: $2000000 (Seed)
  • Hookit: $16000000 (Series C)
  • Hookit: $100000 (Seed)
  • MagicCube: $10000000 (Series A)
  • Werk: $2800000 (Seed Round)
  • Werk: $3000000 (Seed)
  • Werk: $1000000 (Pre Seed)
  • Stratifyd: $7000000 (Series A)
  • Stratifyd: $3000000 (Series A)
  • Stratifyd: $1000000 (Seed)
  • BlockApps: (Series Unknown)
  • Epic: $8000000 (Series C)
  • Epic: $1000000 (Seed)
  • Price.com: $2000000 (Convertible Note)
  • Fresco News: $5000000 (Series A)
  • Fresco News: (Seed)
  • Fresco News: $1000000 (Seed)
  • Visual Vocal: $3000000 (Seed)
  • The Hustle: $1000000 (Seed)
  • Canvs AI: (Series A)
  • Canvs AI: $6000000 (Series A)
  • Sotheby's Home: (Seed)
  • NewsWhip: $6000000 (Series A)
  • NewsWhip: $2000000 (Series Unknown)
  • Jobble: $1000000 (Seed)
  • Kazoo: $7000000 (Series A)
  • Kazoo: (Seed)
  • Locari: (Seed)
  • EntryPoint: $2000000 (Seed)
  • VendorHawk: $1000000 (Seed)
  • Auryc: (Series A)
  • Horton Point: $2000000 (Seed)
  • Clover: $250000 (Series A)
  • Clover: $2000000 (Seed)
  • Clover: $50000 (Seed)
  • FunnelBeam: (Seed)
  • Keeeb: $50000 (Seed)
  • Machine Colony: $50000 (Seed)
  • Inverse: $6000000 (Series A)
  • Inverse: (Seed)
  • Inverse: (Seed)
  • Rheo: $2000000 (Seed)
  • Dexter: $2000000 (Seed)
  • UnaliWear: $4000000 (Series A)
  • YouStake: $50000 (Seed)
  • Pathover (Mixbowl): (Convertible Note)
  • Limitless: $1000000 (Seed)
  • Rad: $5000000 (Series A)
  • Rad: $1000000 (Seed)
  • AlphaPoint: $50000 (Convertible Note)
  • Hush: (Seed)
  • Cleanify: $2000000 (Seed)
  • Listen: (Seed)
  • Unoceros: $50000 (Seed)
  • Unoceros: $25000 (Seed)
  • Slash Keyboard: $1000000 (Seed)
  • hellotoken: $500000 (Angel)

mike edelhart

San Francisco Bay Area - California, U.S.A. - Global: U.S.A., Australia, Canada, Germany, U.K., Israel, France, Italy, Spain, Netherlands, Belgium, Switzerland, Denmark, Finland, Luxembourg, Malta, Iceland

Investing In

BioTech • IoT (& Wearables) • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness)

Description

Joyance Partners is a venture capital firm that invests in companies operating in the healthcare and technology sectors. The firm is based in San Francisco, California.

main investor picture
Thilo Schroeder
Investing in BioTech • Medical Devices (& Ho...
 Zurich, Switzerland
Investor Picture
Previous Investments
  • TP Therapeutics: $80000000
  • Autolus Limited: $80000000 (Later stage VC)
  • Kura Oncology: $60000000 (Other)
  • Jounce Therapeutics: $56000000 (Later stage VC)
  • Peloton Therapeutics: $52400000 (Later stage VC)
  • Cleave Biosciences: $37000000 (Later stage VC)
  • Neon Therapeutics: $36000000 (Later stage VC)
  • TRACON Pharmaceuticals: $27000000 (Later stage VC)
  • ImaginAb: $8000000 (Later stage VC)
  • Circle Pharma: $90000000 (Series D)
  • Circle Pharma: $66000000 (Series C)
  • Circle Pharma: $45000000 (Series B)
  • Alterome Therapeutics: $130000000 (Series B)
  • Alterome Therapeutics: $64000000 (Series A)
  • FogPharma: $150000000 (Series E)
  • Atavistik Bio: $40000000 (Series Unknown)
  • Atavistik Bio: $60000000 (Series A)
  • Exo Therapeutics: $78000000 (Series B)
  • Silverback Therapeutics: $85000000 (Series C)
  • Silverback Therapeutics: $79000000 (Series B)
  • Revolution Medicines: $100000000 (Series C)
  • Revolution Medicines: $56000000 (Series B)
  • IDEAYA Biosciences: $94000000 (Series B)
  • Blueprint Medicines: $25000000 (Series B)

Thilo Schroeder

Zurich, Switzerland

Investing In

BioTech • Medical Devices (& Hospital Services) • Pharmaceutical (& Medicine)

Description

Partner at Nextech Invest

main investor picture
Jun Axup
Investing in BioTech • AgroTech • Food ...
 San Francisco Bay Area, U.S.A. - Global: U.S.A., Australia, Canada, Germany, U.K., Israel, France, Italy, Spain, Netherlands, Belgium, Switzerland, Denmark, Finland, Luxembourg, Malta, Iceland
Investor Picture

Jun Axup

San Francisco Bay Area, U.S.A. - Global: U.S.A., Australia, Canada, Germany, U.K., Israel, France, Italy, Spain, Netherlands, Belgium, Switzerland, Denmark, Finland, Luxembourg, Malta, Iceland

Investing In

BioTech • AgroTech • Food & Beverage • Impact • Pharmaceutical (& Medicine)

Description

Most Interested In

Businesses (not ideas) with complimenting self aware co-founders and proof of product market fit in the form of traction of sales, LOIs, POs, or users.

Not Interested In

Sketchy ICOs.

Join the community

Connect with investors & startup founders

Comprehensive Guides to Finding Startup Investorsin Switzerland

By clicking on "Create Account" you accept our terms of service

Already have an account?
Login
Mike testimonial

Michael Colin - Founder of The MVMT



"We met the perfect Angel Investor within the Angels Partners Investors' Community. We received a $250,000 check after 2 months of discussions with investors on the platform."

Taylor Testimonial

Taylor Matter - Founder & CEO, Hurdle Apparel



"Raising Capital for a consumer venture can be rather difficult and Angels Partners helped connect the dots and helped us meet 2 investors who investors $200,000 in our brand."

founder clement

Clément Perrot - Co-Founder & CEO of Prynt



"Met really good investors who invested in Prynt, that I wouldn’t have met otherwise. Angels Partners helped us close our round quicker and with the right people."


Create An Account
Copyright © 2024 - All trademarks and copyrights belong to their respective owners.
proof notifcation
32 New StartupsStarted their fundraisingover the last 7 days